150 related articles for article (PubMed ID: 22690734)
21. Evidence for involvement of tumor necrosis factor-alpha in apoptotic death of bone marrow cells in myelodysplastic syndromes.
Mundle SD; Ali A; Cartlidge JD; Reza S; Alvi S; Showel MM; Mativi BY; Shetty VT; Venugopal P; Gregory SA; Raza A
Am J Hematol; 1999 Jan; 60(1):36-47. PubMed ID: 9883804
[TBL] [Abstract][Full Text] [Related]
22. Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome.
Sloand EM; Mainwaring L; Fuhrer M; Ramkissoon S; Risitano AM; Keyvanafar K; Lu J; Basu A; Barrett AJ; Young NS
Blood; 2005 Aug; 106(3):841-51. PubMed ID: 15827127
[TBL] [Abstract][Full Text] [Related]
23. In vitro culture studies of childhood myelodysplastic syndrome: establishment of the cell line MUTZ-1.
Steube KG; Gignac SM; Hu ZB; Teepe D; Harms D; Kabisch H; Gaedicke G; Hansen-Hagge T; Macleod RA; Quentmeier H; Drexler HG
Leuk Lymphoma; 1997 Apr; 25(3-4):345-63. PubMed ID: 9168445
[TBL] [Abstract][Full Text] [Related]
24. Application of megakaryocytic morphology in diagnosing 5q- syndrome.
Thiede T; Engquist L; Billström R
Eur J Haematol; 1988 Nov; 41(5):434-7. PubMed ID: 3208866
[TBL] [Abstract][Full Text] [Related]
25. Two cases of myelodysplastic syndrome with extramedullary polyclonal plasma cell proliferation and autoantibody production: possible role of soluble Fas antigen for production of excessive self-reactive B cells.
Katsuki K; Shinohara K; Kameda N; Yamada T; Takeda K; Kamei T
Intern Med; 1998 Nov; 37(11):973-7. PubMed ID: 9868964
[TBL] [Abstract][Full Text] [Related]
26. Analysis of bone marrow and peripheral blood immunoregulatory lymphocytes in patients with myelodysplastic syndrome.
Iwase O; Aizawa S; Kuriyama Y; Yaguchi M; Nakano M; Toyama K
Ann Hematol; 1995 Dec; 71(6):293-9. PubMed ID: 8534761
[TBL] [Abstract][Full Text] [Related]
27. A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome.
Gersuk GM; Beckham C; Loken MR; Kiener P; Anderson JE; Farrand A; Troutt AB; Ledbetter JA; Deeg HJ
Br J Haematol; 1998 Oct; 103(1):176-88. PubMed ID: 9792306
[TBL] [Abstract][Full Text] [Related]
28. Study of p53 in elderly patients with myelodysplastic syndromes by immunohistochemistry and DNA analysis.
Kikukawa M; Aoki N; Sakamoto Y; Mori M
Am J Pathol; 1999 Sep; 155(3):717-21. PubMed ID: 10487829
[TBL] [Abstract][Full Text] [Related]
29. High levels of Ca(2+)-independent endonuclease activity capable of producing nucleosomal-size DNA fragmentation in non-adherent marrow mononuclear cells from patients with myelodysplastic syndromes and acute myelogenous leukemia.
Kawabata H; Anzai N; Ueda Y; Masutani H; Hirama T; Yoshida Y; Okuma M
Leukemia; 1996 Jan; 10(1):67-73. PubMed ID: 8558941
[TBL] [Abstract][Full Text] [Related]
30. Hypermethylation of the calcitonin gene in the myelodysplastic syndromes.
Ihalainen J; Pakkala S; Savolainen ER; Jansson SE; Palotie A
Leukemia; 1993 Feb; 7(2):263-7. PubMed ID: 8426480
[TBL] [Abstract][Full Text] [Related]
31. Biologic characteristics of 164 patients with myelodysplastic syndromes.
Reza S; Dar S; Andric T; Qawi H; Mundle S; Shetty V; Venugopal P; Ali I; Lisak L; Raza A
Leuk Lymphoma; 1999 Apr; 33(3-4):281-7. PubMed ID: 10221507
[TBL] [Abstract][Full Text] [Related]
32. Detection of soluble IL-2 receptor in the serum of patients with myelodysplastic syndromes: induction under therapy with GM-CSF.
Zwierzina H; Herold M; Schöllenberger S; Geissler D; Schmalzl F
Br J Haematol; 1991 Nov; 79(3):438-43. PubMed ID: 1751371
[TBL] [Abstract][Full Text] [Related]
33. Multiple lymphoid nodules in bone marrow have the same clonality as underlying myelodysplastic syndrome recognized with fluorescent in situ hybridization technique.
Mongkonsritragoon W; Letendre L; Li CY
Am J Hematol; 1998 Nov; 59(3):252-7. PubMed ID: 9798667
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of magnetic resonance imaging of femoral marrow in patients with myelodysplastic syndromes.
Takagi S; Tanaka O; Origasa H; Miura Y
J Clin Oncol; 1999 Jan; 17(1):277-83. PubMed ID: 10458243
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of some clinical, morphological and cytogenetic findings in refractory anaemia (RA) and RA with sideroblasts.
Kerndrup G; Pedersen B; Ellegaard J; Hokland P
Blut; 1986 Jan; 52(1):35-43. PubMed ID: 3455830
[TBL] [Abstract][Full Text] [Related]
36. Specific minor chromosome deletions in myelodysplastic syndromes: clinical and morphologic correlations.
Kerndrup G; Pedersen B; Bendix-Hansen K
Cancer Genet Cytogenet; 1987 Jun; 26(2):227-34. PubMed ID: 3567876
[TBL] [Abstract][Full Text] [Related]
37. Incidence and role of apoptosis in myelodysplastic syndrome: morphological and ultrastructural assessment.
Bogdanović AD; Trpinac DP; Janković GM; Bumbasirević VZ; Obradović M; Colović MD
Leukemia; 1997 May; 11(5):656-9. PubMed ID: 9180288
[TBL] [Abstract][Full Text] [Related]
38. Acute leukemia after a primary myelodysplastic syndrome: immunophenotypic, genotypic, and clinical characteristics.
San Miguel JF; Hernández JM; González-Sarmiento R; González M; Sánchez I; Orfao A; Cañizo MC; López Borrasca A
Blood; 1991 Aug; 78(3):768-74. PubMed ID: 1859889
[TBL] [Abstract][Full Text] [Related]
39. Interphase ribosomal RNA cistron silver staining in refractory anaemias with and without excess blasts.
Mamaev NN; Salogub GN; Nefedova IB
Mol Pathol; 1997 Apr; 50(2):92-5. PubMed ID: 9231157
[TBL] [Abstract][Full Text] [Related]
40. Peripheral blood chromosome aberrations in MDS.
White AD; Jacobs A
Cancer Genet Cytogenet; 1992 Apr; 59(2):167-72. PubMed ID: 1581882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
